secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ernexa Therapeutics Inc. (ERNA)
CIK:        0000748592
Form:       8-K
Filed at:   2025-03-24T23:59:59+00:00
Accession:  0001641172-25-000300
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eterna Therapeutics issues $750K promissory note to insider Charles Cherington at 5% due June 2025
--------------------------------------------------------------------------------

- Issued $750,000 promissory note to Charles Cherington, who owns ~32% of ERNA shares.
- Note bears 5% annual interest, payable at maturity; default rate 7%.
- Matures on earliest of June 15, 2025, or when Eterna raises >$5M in equity/convertible debt.
- Cherington also holds a $1.5M note from March 11, 2025, making total insider debt $2.25M.
- Note includes customary events of default, cross-default >$50k, and bankruptcy clauses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/748592/000164117225000300/0001641172-25-000300-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/748592/000164117225000300/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-000300

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer